<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45">
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>ClinicalTrials.gov</collab>
  </person-group> (
  <year>2020c</year>). 
  <source>Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection</source>. Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04324021" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04324021</ext-link> (accessed June 4, 2020).
 </mixed-citation>
</ref>
